Skip to main content

Table 4 Ranking of SF-36/SF-12 Algorithm by Estimated Incremental Cost Utility Ratio

From: Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?

  Incremental Cost 1 year QALYs Gained ICUR ($/QALY) [95% CI] Rank
Asthma     
   Lawrence (SF-12, EQ-5D) $2000 0.065 30 769 [26 316, 36 697] 1
   Franks (SF-12, EQ-5D, MEPS) $2000 0.065 31 008 [26 490, 37 383] 2
   Franks (SF-12, HUI3) $2000 0.061 33 058 [27 778, 40 816] 3
   Franks (SF-12, EQ-5D) $2000 0.058 34 783 [28 986, 43 011] 4
   Lundberg (SF-12, VAS) $2000 0.046 43 956 [37 383, 52 632] 5
   Shmueli (SF-36, VAS) $2000 0.042 47 619 [40 816, 57 971] 6
   Nichol (SF-36, HUI2) $2000 0.038 53 333 [44 444, 66 667] 7
   Fryback (SF-36, QWB) $2000 0.033 60 606 [53 333, 70 175] 8
   Brazier (SF-12, SG) $2000 0.033 61 538 [51 282, 85 106] 9
   Brazier (SF-36, SG) $2000 0.032 63 492 [48 780, 83 333] 10
Stroke     
   Lawrence (SF-12, EQ-5D) $2000 0.067 29 851 [22 599, 43 956] 3
   Franks (SF-12, EQ-5D, MEPS) $2000 0.072 27 972 [20 942, 41 667] 1
   Franks (SF-12, HUI3) $2000 0.067 30 075 [22 599, 44 944] 4
   Franks (SF-12, EQ-5D) $2000 0.070 28 777 [20 942, 45 455] 2
   Lundberg (SF-12, VAS) $2000 0.040 50 000 [35 088, 88 889] 8
   Shmueli (SF-36, VAS) $2000 0.028 72 727 [48 780, 148 148] 10
   Nichol (SF-36, HUI2) $2000 0.045 44 944 [33 058, 68 966] 6
   Fryback (SF-36, QWB) $2000 0.035 57 971 [44 944, 83 333] 9
   Brazier (SF-12, SG) $2000 0.044 45 977 [33 058, 74 074] 7
   Brazier (SF-36, SG) $2000 0.058 34 483 [27 211, 46 512] 5
  1. NB: algorithms are ordered from lowest to highest ICUR in the asthma patients